Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
AL044 Alzheimer's Disease (Phase 1) Alector Inflammation Immunotherapy (passive)
CpG 1018® CpG oligodeoxynucleotides,
CpG ODN
Alzheimer's Disease (Phase 1) Dynavax Technologies Amyloid-Related, Inflammation Immunotherapy (active), DNA/RNA-based
Edicotinib JNJ-40346527,
JNJ-527,
PRV-6527
Alzheimer's Disease (Phase 1) Janssen Inflammation Small Molecule
GC021109 Alzheimer's Disease (Phase 1) GliaCure Inflammation Small Molecule
IBC-Ab002 Alzheimer's Disease (Phase 1) ImmunoBrain Checkpoint Amyloid-Related, Inflammation, Other Immunotherapy (passive)
Inzomelid Alzheimer's Disease (Phase 1), Parkinson's Disease (Phase 1) Inflazome Ltd. Inflammation Small Molecule
MW151 MW01-2-151SRM,
Minozac,
MW01-2-151WH,
compound 17
Alzheimer's Disease (Phase 1) ImmunoChem Therapeutics, LLC Inflammation Small Molecule
NTRX-07 MDA7 Alzheimer's Disease (Phase 1) NeuroTherapia, Inc. Inflammation, Other Small Molecule
Protollin Alzheimer's Disease (Phase 1) I-MAB Biopharma Co., Ltd., Jiangsu Nhwa Pharmaceutical Co., Ltd Inflammation Immunotherapy (active)
SNP318 Alzheimer's Disease (Phase 1) SciNeuro Pharmaceuticals Inflammation Small Molecule
TB006 Alzheimer's Disease (Phase 1) TrueBinding, Inc. Inflammation Immunotherapy (passive)